- Home
- PRE vs IMRX Comparison
PRE vs IMRX Comparison
Compare PRE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- IMRX
- Stock Information
- Founded
- PRE 2014
- IMRX 2008
- Country
- PRE Hong Kong
- IMRX United States
- Employees
- PRE N/A
- IMRX N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- IMRX Health Care
- Exchange
- PRE Nasdaq
- IMRX Nasdaq
- Market Cap
- PRE 52.5M
- IMRX 62.7M
- IPO Year
- PRE N/A
- IMRX 2021
- Fundamental
- Price
- PRE $5.19
- IMRX $1.19
- Analyst Decision
- PRE Buy
- IMRX Strong Buy
- Analyst Count
- PRE 1
- IMRX 3
- Target Price
- PRE $9.00
- IMRX $15.33
- AVG Volume (30 Days)
- PRE 10.6K
- IMRX 166.9K
- Earning Date
- PRE 06-17-2025
- IMRX 05-05-2025
- Dividend Yield
- PRE N/A
- IMRX N/A
- EPS Growth
- PRE N/A
- IMRX N/A
- EPS
- PRE N/A
- IMRX N/A
- Revenue
- PRE $30,621,000.00
- IMRX N/A
- Revenue This Year
- PRE $148.70
- IMRX N/A
- Revenue Next Year
- PRE $82.89
- IMRX N/A
- P/E Ratio
- PRE N/A
- IMRX N/A
- Revenue Growth
- PRE 40.83
- IMRX N/A
- 52 Week Low
- PRE $3.10
- IMRX $1.00
- 52 Week High
- PRE $6.99
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- PRE 65.84
- IMRX 39.94
- Support Level
- PRE $5.07
- IMRX $1.10
- Resistance Level
- PRE $5.40
- IMRX $1.30
- Average True Range (ATR)
- PRE 0.34
- IMRX 0.11
- MACD
- PRE 0.06
- IMRX -0.01
- Stochastic Oscillator
- PRE 75.91
- IMRX 21.95
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.